QQ客服 官方微博 反馈留言

	Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.
	Hu Tinghua; Yu Shuo; Cheng Chuantao; Wang Jing; Wang Jia; Qu Zhan; Li Yang; Ren Hui; Ning Qian; Chen Mingwei
刊名	Anti-cancer agents in medicinal chemistry
	2018
卷号	18页码:1680-1687
关键词	clinicopathological prognostic biomarker Beclin1 non-small cell lung cancer Nrf2
ISSN号	1875-5992
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2830804
专题	西安交通大学
推荐引用方式 GB/T 7714	Hu Tinghua,Yu Shuo,Cheng Chuantao,et al. Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.[J]. Anti-cancer agents in medicinal chemistry,2018,18:1680-1687.
APA	Hu Tinghua.,Yu Shuo.,Cheng Chuantao.,Wang Jing.,Wang Jia.,...&Chen Mingwei.(2018).Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer..Anti-cancer agents in medicinal chemistry,18,1680-1687.
MLA	Hu Tinghua,et al."Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.".Anti-cancer agents in medicinal chemistry 18(2018):1680-1687.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。